ePrints

AlphaE integrin expression as a predictive biomarker for induction of clinical remission by etrolizumab: Analysis of a phase II trial in moderate-to-severely active ulcerative colitis

Lookup NU author(s): Dr Michael Keir, Dr John Mansfield, Dr Chris LambORCiD, Emeritus Professor John Kirby

Downloads

Full text for this publication is not currently held within this repository. Alternative links are provided below where available.

Publication metadata

Author(s): Keir M, Tew GW, Luca D, Eastham-Anderson J, Diehl L, Egen JG, Vermeire S, Mansfield JC, Lamb CA, Panes J, Baumgart DC, Schreiber S, Dotan I, Sandborn WJ, De Hertogh G, Kirby JA, Van Assche G, Rutgeerts P, O'Byrne S

Publication type: Conference Proceedings (inc. Abstract)

Publication status: Published

Conference Name: 9th Congress of ECCO

Year of Conference: 2014

Pages: S7-S7

Print publication date: 01/02/2014

Online publication date: 01/02/2014

Acceptance date: 01/01/1900

ISSN: 1876-4479

Publisher: Oxford University Press

URL: https://doi.org/10.1016/S1873-9946(14)60011-8

DOI: 10.1016/S1873-9946(14)60011-8

Series Title: Journal of Crohn's and Colitis

Share